🇺🇸 FDA
Patent

US 10233161

Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid

granted A61KA61K31/4245A61K9/0048

Quick answer

US patent 10233161 (Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid) held by PTC THERAPEUTICS, INC. expires Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PTC THERAPEUTICS, INC.
Grant date
Tue Mar 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/4245, A61K9/0048, A61P, A61P27/02